Gel ointment for treating tinea capitis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN WEALTH BIOENGINEERING SCI & TECH CO LTD
- Publication Date
- 2007-03-14
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention belongs to a gel ointment for treating tinea capitis. Background technique
[0002] Tinea capitis is divided into three types: black tinea, white tinea and yellow tinea. The pathogenic bacteria are some bacteria in the genus Trichophyton and Microsporum. Tinea capitis can result from direct or indirect contact with a patient or infected animal. Oral griseofulvin has a good effect on the treatment of tinea capitis. But oral administration can cause gastrointestinal obstruction, headache, hives and other symptoms. Currently, there is a solvent on the market. Because griseofulvin is insoluble in the base, it exists in a suspended state in fat-soluble or water-soluble bases, which affects skin absorption and has poor application effect. Therefore, there is an urgent need in the market for a product that has a significant therapeutic effect on tinea capitis and will not cause gastrointestinal obstruction, headache and hives. Contents of t...